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Abstract: Peptides derived from amphibian skin secretion are promising drug prototypes for
combating widespread infection. In this study, a novel peptide belonging to the phylloseptin family
of antimicrobial peptides was isolated from the skin secretion of the Phyllomedusa camba, namely
phylloseptin-PC (PSN-PC). The biosynthetic precursor was obtained by molecular cloning and the
mature peptide sequence was confirmed through tandem mass spectrometry (MS/MS) fragmentation
sequencing in the skin secretion. The synthetic replicate exhibited a broad spectrum antimicrobial
activity against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Escherichia coli,
Pseudomonas aeruginosa, Candida albicans at concentrations of 2, 2, 8, 32 and 2 µM, respectively.
It also showed the capability of eliminating S. aureus biofilm with a minimal biofilm eradication
concentration of 8 µM. The haemolysis of this peptide was not significant at low concentrations
but had a considerable increase at high concentrations. Additionally, this peptide showed an
anti-proliferation effect on the non-small cell lung cancer cell line (NCI-H157), with low cytotoxicity
on the human microvascular endothelial cell line (HMEC-1). The discovery of the novel peptide may
provide useful clues for new drug discoveries.
Keywords: antimicrobial peptide; phylloseptin; anti-biofilm activity; cancer cell cytotoxicity
1. Introduction
Amphibian skin secretion consists of various bioactive peptides that play an essential role in
amphibian survival. These peptides demonstrated multifunctional activities against Gram-negative
and Gram-positive bacteria, fungi, enveloped viruses and even cancer cells [1]. Additionally, some
other peptides are considered potentially to be immunomodulatory and anti-diabetic agents [2],
and even contraceptives, as they can be cytotoxic to sperm [3]. These skin-derived antimicrobial
peptides (AMPs) are especially predominant and demonstrate board spectrum antimicrobial activity,
which make them potential drug candidates in the treatment of bacterial infections. These AMPs are
able to efficiently kill antibiotic-resistant bacteria and have little chance for inducing serious drug
resistance [4]. Some AMPs have been reported to be capable of inhibiting biofilm formation as well
as eradicating mature biofilm [5], which makes bacteria 1,000-fold more resistant to conventional
antimicrobial agents than their planktonic counterparts.
Among all the AMPs, α-helical antimicrobial peptides, such as magainins [6] and dermaseptins [7],
have been extensively studied regarding their biosynthesis, antimicrobial activity, mechanism
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of action, three-dimensional structures, and further applications. However, the phylloseptins
have not attracted much attention. Several phylloseptins were first identified in 2005, showing
anti-bacterial and anti-protozoan peptide activities, from the skin secretion of the Brazilian tree-frogs,
Phyllomedusa hypochondrialis and Phyllomedusa oreades [8]. Besides, Yasser et al. found a phylloseptin
from the skin of the frog Hylomantis lemur induced insulin release from the rat BRIN-BD11 clonal β cell
line, providing a promising alternative for treating Type 2 diabetes [9].
In the present study, the isolation of a novel phylloseptin precursor from the Phyllomedusa camba
skin secretion, which has been rarely studied so far, was conducted by ”shotgun” molecular cloning.
The primary structure of the peptide was confirmed by tandem mass spectrometry (MS/MS)
fragmentation and named phylloseptin-PC (PSN-PC). The replicate was then chemically synthesised
and purified for downstream study. Subsequently, experiments were designed to evaluate the effects of
PSN-PC on microorganisms, cancer cell lines and its toxicity to horse erythrocytes and normal human
cells of the human microvascular endothelial cell line (HMEC-1). Furthermore, the secondary structure
of this novel peptide was predicted and time-killing curves along with bacterial cell membrane
permeability assays were performed to explore its mechanism of action.
2. Results
2.1. Molecular Cloning of a Novel AMP Precursor-Encoding cDNA and Bioinformatic Analyses
A full-length cDNA encoding the biosynthetic precursor of PSN-PC was consistently and
successfully cloned from the skin secretion library (Figure 1). The alignment of phylloseptins shows
that the members share a highly-conserved amino acid sequence in the phylloseptin family (Figure 2).
There were several typical characteristics in the translated open reading frame: (1) a highly-conserved
putative signal peptide region of 22 amino acid residues, which is homologous to each other; (2) acidic
spacer peptide region consisting of Glu, Asp and other hydrophilic amino acids; (3) a classical
propeptide convertase processing site (-KR-); (4) a mature active peptide encoding domain that
contained 19 amino acid residues; and (5) the C-terminal glycine residue acted as an amide donor.
The significant variations occurred in the mature peptide domain were at the position 7, 9, 10, 13, 14
and 15. The nucleotide sequence of this PSN-PC precursor was deposited in the Genbank Nucleotide
Sequence Database under the accession code, MF797869.
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Figure 1. Nucleotide and translated open-reading frame amino acid sequence of biosynthetic precursor
cDNA encoding the novel mature peptide. The putative signal peptide is single-underlined, the mature
peptide is double-underlined, and the stop codon is indicated by an asterisk.
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indicates consensus amino acid residues, and green shading indicates similar amino acid residues. 
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The fractions of skin secretion resolved by reverse-phase high performance liquid chromatography 
(RP-HPLC) are shown in Figure 3a, with an arrow indicating the retention time/elution position of 
the peptide with the predicted peptide mass. The fraction that yielded the predicted peptide mass 
was further analysed by MS/MS fragmentation (Figure 3b,c). The ion 980.28 m/z was considered as a 
NH3 loss from the parent ion, which also indicated the C-terminal amindation. 
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2.2. Fractionation of Skin Secretion, Identification and Structural haracterisation of PS -PC
The fractions of skin secretion resolved by reverse-phase high perfor ance liquid chro atography
(RP- PLC) are shown in Figure 3a, with an arrow indicating the retention time/elution position of the
peptide with the predicted peptide mass. The fraction that yielded the predicted peptide mass was
further analysed by MS/ S fragmentation (Figure 3b,c). The ion 980.28 m/z was considered as a NH3
loss from the parent ion, which also indicated the C-terminal amindation.
Molecules 2017, 22, 1896 3 of 16 
 
 
Figure 2. ultiple alignments of the cloned cDNA-deduced amino acid sequence of phylloseptins 
with antimicrobial activities. Grey shading indicates identical amino acid residues, yellow shading 
indicates consensus amino acid residues, and green shading indicates similar amino acid residues. 
(1): putative signal peptide; (2): acidic spacer peptide region; (3): dibasic propeptide convertase 
processing site; (4): mature peptide; (5): glycine residue amide donor. 
. . ractio ti  f i  ecreti , I e tific ti   tr ct r l C r cteris ti  f N-  
 fr ti s f i  r ti  r l   r r -  i  rf rm  li i  r m t r  
( -H ) re shown in Figure 3a, with an arrow indicating th  retention time/elution positi n of 
the peptide with th  predicted peptide mass. The fraction that yielded th  predict d peptide mas  
was further analysed by M /MS fragmentation (Figure 3b,c). The ion 980.28 m/z was consi ered as a 
NH3 loss from th  pare t ion, which also indicat d th  C-terminal amindation. 
 
(a) 
A
U
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00
2.20
2.40
2.60
2.80
3.00
Minutes
0.00 20.00 40.00 60.00 80.00 100.00 120.00 140.00 160.00 180.00 200.00 220.00 240.00
Figure 3. Cont.
Molecules 2017, 22, 1896 4 of 16
Molecules 2017, 22, 1896 4 of 16 
 
 
(b) 
 
(c) 
Figure 3. (a) Reverse phase high performance liquid chromatography (HPLC) chromatogram of skin 
secretion of Phyllomedusa camba monitored at 214 nm. The arrow indicated the retention time of 
PSN-PC; (b) Tandem mass (MS/MS) fragmentation spectrum of PSN-PC; (c) Predicted singly-charged 
b ions and y ions arising from MS/MS fragmentation. The observed b- and y-ions were indicated in 
blue and red typefaces.  
2.3. Conformational Study 
The purified product of solid-phase peptide synthesis was successfully obtained by RP-HPLC 
and MALDI-TOF MS with a high degree of purity (Figure 4a,b). The observed molecular weight of 
PSN-PC was 1976.11Da (Figure 4b) which was consistent with that of the natural peptide. This 
peptide contained a large proportion of α-helical domain with a series of high scores representing a 
more confident prediction of secondary structure (Figure 4c). Similarily, a three-dimensional 
simulation of the synthetic peptide exhibited the structural feature of coil-helix-coil (Figure 4d). 
Z-score of PSN-PC was within the range of scores typically found for native proteins of similar size, 
indicating that the overall model quality is reliable (Figure 4e). Moreover, the helical wheel 
projection predicted that the peptide had an obvious propensity for the α-helix formation which 
was typical in most AMPs (Figure 4f). An amphipathic structure was observed with the 
hydrophobic residues (L4, L15, I8, F1, L19, I12, I5, A16, A9) and cationically hydrophilic residues 
(H18, K7, K17) partitioning on opposites of the molecule. Finally, the circular dichroism (CD) results 
Figure 3. (a) Reverse phase high performance liquid chromatography (HPLC) chromatogram of skin
secretion of Phyllomedusa camba monitored at 214 nm. The arrow indicated the retention time of PSN-PC;
(b) Tandem mass (MS/MS) fragmentation spectrum of PSN-PC; (c) Predicted singly-charged b ions
and y ions arising from MS/MS fragmentation. The observed b- and y-ions were indicated in blue and
red typefaces.
2.3. Conformational Study
The purified product of solid-phase peptide synthesis was successfully obtained by RP-HPLC
and MALDI-TOF MS with a high degree of purity (Figure 4a,b). The observed molecular weight of
PSN-PC was 1976.11Da (Figure 4b) which was consistent with that of the natural peptide. This peptide
contained a large proportion of α-helical domain with a series of high scores representing a more
confident prediction of secondary structure (Figure 4c). Similarily, a three-dimensional simulation of
the synthetic peptide exhibited the structural feature of coil-helix-coil (Figure 4d). Z-score of PSN-PC
was within the range of scores typically found for native proteins of similar size, indicating that the
overall model quality is reliable (Figure 4e). Moreover, the helical wheel projection predicted that
the peptide had an obvious propensity for the α-helix formation which was typical in most AMPs
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(Figure 4f). An amphipathic structure was observed with the hydrophobic residues (L4, L15, I8, F1,
L19, I12, I5, A16, A9) and cationically hydrophilic residues (H18, K7, K17) partitioning on opposites of
the molecule. Finally, the circular dichroism (CD) results of PSN-PC exhibited an unordered structure
in 10 mM ammonium acetate buffer but typically α-helical bands at around 208 nm and 220 nm in 50%
TFE ammonium acetate buffer (Figure 4g). These typical characteristics suggest that PSN-PC adopt a
well-defined α-helical structure when in contact with a hydrophobic environment.
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strongest antibacterial activity against the growth of S. aureus and C. albicans. It exhibited ~2-fold 
more potent antimicrobial activity than Phylloseptin-PBa, Phylloseptin-PTa, PS-Co and PS-Du 
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all three PSN-PC concentrations were able to kill bacteria at similar rates, but 2 and 4 × MIC killed 
more bacteria, leading to 100 CFU/mL at 2 h. After that period, 2 and 4 × MIC of PSN-PC continued 
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PSN-PC showed a recovery trend in the next 4 h. Further investigation of the cell-membrane 
permeabilisation of S. aureus after the 2 h incubation with corresponding concentrations of PSN-PC 
and bacteria cells were performed and the results showed that PSN-PC induced about 45% of 
Figure 4. (a) The RP-HPLC chromatogram of the purifie synthetic phylloseptin-PC (PSN-PC);
(b) MALDI-TOF mass spe rum of synthetic PSN-PC; (c) Predicted secondary struc ure of PSN-PC
using I TASSER; (d) Predict d 3D model of PSN-P using I-TASSER; (e) Z-score plot using ProSA-web;
(f) Helical wheel plot of PSN-PC; (g) Circular dichroism (CD) spectra recorded for PSN-PC (100 µM) in
10 mM ammonium acetate buffer and 50% TFE ammonium acetate buffer.
2.4. Bioactivity Assays of PSN-PC
The peptide tested possessed significant bioactivity against Gram-positive bacteria
Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA) and the yeast Candida
albicans at the sam minimum inhibitory concentration (MIC) of 2 µM (Table 1). This pep ide was also
potent against the Gram-n gative bacteria Escherichia coli and Pseudomonas aeruginosa (MIC of 8 and 32 µM,
respectively). The MIC values of the phyll septin were aligned in Figure 2 and their corresponding
physicochemical parameters listed in Table 2 [8,10–15]. PSN-PC demonstrated the strongest antibacterial
activity against the growth of S. aureus and C. albicans. It exhibited ~2-fold more potent antimicrobial
activity than Phylloseptin-PBa, Phylloseptin-PTa, PS-Co and PS-Du against S. aureus. Also, PSN-PC
showed slightly weaker inhibitory effects than Phylloseptin-7 against E. coli. Besides, it eradicated mature
S. aureus biofilm at a minimal biofilm eradication concentration (MBEC) of 8 µM (Figure 5).
The number of bacteria started to decrease in the first 30 min with the presence of 2 and 4 ×
MIC of PSN-PC, while the population remained constant at 1 × MIC (Figure 6a). During 0.5–2 h,
all three PSN-PC concentrat ons were able to kil bacteria at similar rates, but 2 and 4 × MIC killed
more bacteria, leading to 100 CFU/mL at 2 h. After that period, 2 and 4 × MIC of PSN-PC continued
to kill bacteria until a state in which surviving cells could not be counted. While low doses of PSN-PC
showed a recovery trend in the next 4 h. Further investigation of the cell-membrane permeabilisation
of S. aureus after the 2 h incubation with corresponding concentrations of PSN-PC and bacteria
cells were performed and the results showed that PSN-PC induced about 45% of cell-membrane
permeabilisation at 2 µM on S. aureus (Figure 6b). Higher concentrations of PSN-PC led to ~2-fold
increase of membrane permeabilisation.
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PSN-PC had a significant anti-proliferative effect on the non-small cell lung cancer cell line NCl-H157
with an IC50 of 2.85 µM (Figure 7a). Comparatively, the human microvessel endothelial cell line HMEC-1
was used to evaluate the inherent cytotoxicity of PSN-PC against normal human cells, which showed
an IC50 of 51.83 µM (Figure 7b). PSN-PC had ~100% haemolysis at 64 µM, (Figure 8). The whole
haemolytic process was divided into three parts, including a low degree of haemolysis at the initial stage
(1–8 µM), a sharp rise in the middle stage (8–64 µM), and finally a constant period of complete haemolysis.
The concentration of the test peptide which induced 50% haemolysis (HC50) was 23 µM.
Table 1. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs)
of PSN-PC.
Strains S. aureus MRSA C. albicans E. coli P. aeruginosa
MIC (µM) 2 2 2 8 32
MBC (µM) 4 4 2 8 64
Table 2. Minimum inhibitory concentrations (MICs) and corresponding physicochemical parameters
of natural phylloseptin AMPs against specified microorganisms.
Peptide Name MIC (mg.L
−1/µM)
<H> <µH> Net Charge
S. aureus E. coli C. albicans
Phylloseptin-PHa 64/33 >512/>264 256/131.9 0.799 0.457 0
PS-PT 55/26.4 55/26.4 55/26.4 0.686 0.438 + 2
PLS-S2 12.7/6.3 50.9/25 ND 0.801 0.548 + 1
PLS-S4 12.5/6.3 50.1/25 ND 0.789 0.519 + 1
Phylloseptin-7 12/6 12/6 ND 0.745 0.513 + 1
Phylloseptin-PBa 8/4.2 128/67.6 8/4.2 0.711 0.637 + 2
Phylloseptin-PTa 8/4.1 32/16.6 4/2.1 0.740 0.577 + 2
PS-Co 8/4.1 128/64.9 16/8.1 0.706 0.636 + 2
PS-Du 8/3.90 128/62.5 16/7.8 0.725 0.624 + 2
PSN-PC 4/2 16/8 4/2 0.754 0.563 + 2
<H>: Hydrophobicity; <µH>: Hydrophobic moment; ND: not detected. MICs came from publications [8,10–15],
and their physicochemical parameters were calculated by online analysis tool, HeliQuest.
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Molecules 2017, 22, 1896 9 of 16
immunomodulatory effects [16]. So far, 48 phylloseptins have been deposited in the Uniprot database
and all were isolated from phyllomedusinae tree frogs (P. sauvagii, P. bicolor, P. oreades etc.) in South
American countries, such as Brazil and Colombia [4,17]. In this study, PSN-PC was found from a virtually
unstudied species of phyllomedusine frog in South America, Phyllomedusa camba, with homologies to other
phylloseptins from P. sauvagii, P. bicolor, |P. hypochondrialis and P. azurea [18].
Phylloseptin peptides share common characteristics, such as a highly-conserved hexapeptide
(FLSLIP-) in the N-terminal region (Figure 2) and C-terminal amidation, which has been shown to
promote biological activity [19]. Lee et al. reported that a kink which was potentially introduced by proline
was responsible for the helix distortion [20]. Importantly, Khara et al. found that backbone sequence
comprising of (X1Y1Y2X2)n (X1 and X2 are hydrophobic amino acids, Y1 and Y2 cationic amino acids,
and n the number repeat units) exhibited broad-spectrum antimicrobial activities against drug-resistant
and biofilm-associated infections [21]. In the phylloseptin family, the C-terminal tetrapeptide was
consistent with the proposed motif. The aligned phylloseptin ending with a terminal Leu generally
showed more potent antimicrobial activity than when ending with a Phe. The changes of antimicrobial
effect may be related to the different amino acid compositions in the C-terminal tetrapeptide. Interestingly,
the antimicrobial activity of phylloseptin could be affected by amino acid substitutions occurred at
specific positions. For instance, Phylloseptin-PTa only had one amino acid difference with PSN-PC at
position 10, from Gly to Thr, resulting in a 2-fold increase of antibacterial activity against S. aureus and
E. coli. Additionally, the same change occurred between phylloseptin-PBa and PS-Du with antifungal
activity reduced by half but with no changes in antibacterial activity. On the other hand, a Leu substituted
by a Met at position 4, could generally result in relative higher antimicrobial efficacy. These common
adaptations within peptide families not only shed light on phylogenetic information relevant to genetic
mutations during natural selection, but also are helpful for future designs of antibiotic drugs.
Combining the results of time-killing curves and the cell membrane permeability assay (Figure 6),
it is reasonable to think that the mechanism of action by 1 × MIC might be different from that at 2 ×
MIC (or 4×MIC). It is presumed that at lower concentrations (1×MIC), the peptide is unable to cover
the entire lipid layer leading to the formation of transient, toroidal lipid-peptide pores only within
a limited range, which agreed with a previously publication [22]. While at higher concentrations
(2 or 4 × MIC), more complex antimicrobial mechanisms of mode may arise, such as a mixture of
carpet mechanism and toroidal pore mechanism. Hallock et al. reported that MSI-78, an amphipathic
α-helical AMP, resulted in the formation of a mixture of normal hexagonal phase and lamellar phase
lipids at higher peptide concentrations [23].
Natural phylloseptins normally possess positive charges ranging from 0 to +2 (Table 2). Within
a certain number of positively charged residues (usually 5–6), the increasing of net charge made these
peptides more active for antimicrobial activity. Beyond the charge magnitude, the role of positive charges
of a particular peptide can be limited [24]. PS-PT was an exception because its hydrophobicity (0.686)
was lower than others (>0.7). Chen et al. claimed that there was an optimal hydrophobicity window in
which high antimicrobial activity could be obtained. Decreased or increased hydrophobicity beyond this
window resulted in a sharp decrease in antimicrobial efficacy [25]. Meanwhile, higher hydrophobicity was
correlated with stronger haemolytic activity. This can be explained by the strong peptide self-association
that hinders a peptide from passing through the cell wall in prokaryotic cells without affecting the access to
eukaryotic membranes [26]. The peptide self-association might be an important reason for the significant
haemolysis of PSN-PC (100% haemolysis at 64 µM). Park et al. synthesized an N-terminal random coil
deleted A3-NT from an amphipathic AMP HP-A3, and the shorter peptide showed increased antibacterial
and antifungal activity [27]. Physicochemical parameters, such as length, sequence, and hydrophobicity,
are intimately correlated and replacing a single factor induces changes to the others.
Compared to published phylloseptins, PSN-PC exhibited the more potent antimicrobial activity,
especially against the Gram positive bacterium, S. aureus, and anti-yeast activity with the lowest
MIC of 2 µM, making PSN-PC the most effective compound among the majority of reported
phylloseptins [8,10–15]. Some studies have also evaluated the susceptibility of sessile S. aureus in
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biofilm, resulting in chronic and recurring bacterial infections in humans and high levels of antibiotic
tolerance [28]. PSN-PC significantly eradicated the biofilm of S. aureus at 8 µM, showing a slightly
weaker effectiveness compared to its bioactivity against planktonic S. aureus. PSN-PC is considered to
remove microorganisms by interacting with bacterial membranes and causing pore formation, lysis
and microbicidal death, which was consistent with the antimicrobial strategy [29].
Interestingly, because of the fact that cancer cells generally have more phosphatidylserine in the
outer leaflet of the membrane than in normal cells, they are more susceptible to the lytic action of
AMPs [30]. However, PSN-PC shows a broad-spectrum antimicrobial activity and no effect on tested
cancer cells except for NCl-H157. The reason for selective killing of bacteria and cancer cells by PSN-PC
could be related to distinct compositions of bacterial and cancer cell membranes and different structural
transformations of peptides when in contact with different membranes. A possible explanation for this
might be that the negative charges carried by NCI-H157 are more than that of other cancer cells tested.
In fact, a recent study has shown that DRS-B2 resulted in the necrosis of PC3 cancer cells through a rapid
membrane disruption [31]. The accepted antimicrobial mechanism is complicated and non-specific,
not involving binding to a receptor [32]. The cationic compounds can interact with the negatively
charged components of bacterial and cancer cells and the interaction may influence the strong link
and selective disruption of bacterial and cancer cell membranes [33]. The non-specific interaction of
AMPs with cell membranes results in the loss of membrane integrity, leakage of intercellular contents
which eventually producing cell death. On the other hand, the cross-resistance of microorganisms to
AMPs would be less likely to occur since the mechanisms of mode of amphipathic natural peptides are
unrelated to conventional antibiotics, which is consistent with the finding of Stark et al. [34].
In conclusion, a novel peptide PSN-PC was first isolated from the skin secretion of
Phyllomedusa camba and properly tested against various microbes. PSN-PC showed potent activity
against bacteria, fungi and exhibited anti-tumor activity against the non-small cell lung cancer
cell line NCl-H157. Furthermore, it demonstrated the significant capacity of eradicating S. aureus
biofilm infections. In fact, the multifunctional peptide is the most effective AMP among most of the
phylloseptins from natural sources. Its excellent broad-spectrum antimicrobial activities make it a
possible candidate for antimicrobial and anti-biofilm agents. These findings may provide useful clues
regarding new agents for treating recurrent infections.
4. Materials and Methods
4.1. Acquisition of Skin Secretion
Specimens of the frog Phyllomedusa camba (n = 3) were obtained from commercial sources. The skin
secretion was obtained via mild squeezing and massaging the dorsal skin of frogs, after which the
frogs were released. The viscous white skin secretion was washed from the skin using deionised water,
snap-frozen in liquid nitrogen, lyophilised and stored at−20 ◦C before analysis. The study was performed
according to the guidelines in the UK Animal (Scientific Procedures) Act 1986, project license PPL 2694,
issued by the Department of Health, Social Services and Public Safety, Northern Ireland. Procedures had
been vetted by the IACUC of Queen’s University Belfast, and approved on 1 March 2011.
4.2. “Shotgun” Cloning of a Phyllomedusa camba Skin Secretion-Derived cDNA Library
Five milligrams sample of lyophilised Phyllomedusa camba skin secretion were dissolved in 1 mL
of cell lysis/mRNA stabilisation buffer (Dynal, Merseyside, UK). Then the polyadenylated mRNA was
isolated utilizing magnetic oligo-dT beads under the guidance of the manufacturer (Dynal, Merseyside,
UK) and the isolated mRNA was subsequently subjected to 5’- and 3’-rapid amplification of cDNA
end (RACE) procedures to acquire full-length prepropeptide nucleic acid sequence data by using
a SMART-RACE kit (Clontech, Oxford, UK) essentially as outlined by the manufacturer. Briefly,
the 3’-RACE reactions employed a nested universal (NUP) primer and degenerate sense primer (S1;
5’-ACTTTCYGAWTTRYAAGMCCAAABATG-3’ (Y = C/T, W = A/T, R = A/G, M = A/C, B = T/C/G)
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that were designed to highly-conserved segments of the signal peptides of cDNAs cloned previously
from other Phyllomedusa frogs within our group [35]. The PCR cycling procedure included an initial
denaturation at 94 ◦C for 90 s and 35 cycles for further denaturation at 94 ◦C lasting for 30 s, after
which followed primer annealing for 30 s at 58 ◦C and extension for 180 s at 72 ◦C. PCR products were
gel-purified and cloned using a pGEM-T vector system (Promega Corporation, Southampton, UK) and
sequenced using an ABI 3100 automated sequencer (Applied Biosystems, Foster City, CA, USA).
4.3. Identification and Structural Analysis of PSN-PC
Five mg of lyophilised skin secretion of Phyllomedusa cambawas dissolved in 0.5 mL of trifluoroacetic
acid (TFA)/water and the supernatants were centrifuged at 2500× g for 5 min and pumped to an analytical
reversed phase HPLC Jupiter C5 column (250 mm × 4.6 mm, Phenomenex, UK). All fractions were
eluted from the column using a gradient programme which ran over 240 min at a flow rate of 1 mL/min
from water/TFA (99.95/0.05, v/v) to acetonitrile/water/TFA (80/19.95/0.05; v/v/v). A Cecil CE4200
Adept gradient reverse phase HPLC (Cecil, Cambridge, UK) was used to collect fractions at 1 min
intervals. All fractions were analysed by time-of-flight mass spectrometry (MALDI-TOF MS) (Voyager
DE, Perspective Biosystems, Foster City, CA, USA) with _α-cyano-4-hydroxycinnamic acid (CHCA) as
the matrix in positive mode. The instrument was calibrated by standards and set accuracy was ±0.1%.
The peptide containing a molecular mass coincident with that predicted from cloned cDNA, was injected
into a LCQ-Fleet electrospray ion-trap mass spectrometer to determine its primary structure by MS/MS
fragmentation (Thermo Fisher Scientific, San Francisco, CA, USA).
4.4. Solid-Phase Peptide Synthesis
The replicate was synthesised by solid-phase Fmoc chemistry using Rink amide resin in a Tribute
automated peptide synthesiser (Protein Technologies, Tucson, AZ, USA) when the unequivocal primary
structure of the novel peptide had been confirmed. The reaction involved deprotection of the Fmoc
groups from the amino acids and coupling of peptide bonds. When the synthesis cycles were completed,
the peptide was cleaved from the resin using trifluoroacetic acid (TFA), triisopropylsilane (TIPS) and water
(95/2.5/2.5, v/v/v) for 25 mL/g resin. The authenticity of the purified synthetic PSN-PC was verified by
RP-HPLC with an analytical Jupiter C5 column (250 mm × 4.6 mm, Phenomenex, UK). The sample was
eluted with a linear gradient from water/TFA (99.95/0.05, v/v) to acetonitrile/water/TFA (80/19.95/0.05;
v/v/v) in 40 min at a flow rate of 1 mL/min. The degree of purity and authentication of the purified
synthetic peptide was determined by RP-HPLC (Cecil, Cambridge, UK) and MALDI-TOF MS (Voyager
DE, Perspective Biosystems, Foster City, CA, USA) as previously described [36].
4.5. Circular Dichroism (CD) Spectroscopy
The secondary structure of the peptide was determined using a JASCO J-815 CD spectrometer
(Jasco, Essex, UK). It was dissolved in 10 mM ammonium acetate and 10 mM ammonium acetate with 50%
trifluoroethanol (TFE), respectively and then was prepared at 100 µM in a 1 mm high precision quartz cell
(Hellma Analytics, Essex, UK). CD spectra were recorded at a wavelength ranging from 190 nm to 250 nm
with a 100 nm/min scan speed. The parameters were set as 1 nm bandwidth and 0.5 nm data pitch.
We supplemented the secondary structure prediction with some bioinformatics tools.
A vividly visual plot containing some further details about alpha helices was demonstrated by
helical wheel projections. The significant properties of the novel peptide were predicted by
Heliquest (http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParams.py). Additionally, the I-TASSER
webserver [37,38] was utilized to simulate a 3D model. Overall qualities of the predicted model were
evaluated by z-scores using ProSA [39,40].
4.6. Antimicrobial Activities
The broth dilution method [41] was referred and slightly modified to evaluate the antimicrobial
activity of the novel peptide. In short, different concentrations of the peptide ranging from 1 to 512 µM
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were incubated with microorganisms under defined conditions. These microorganisms consisted
of the Gram-positive bacteria Staphylococcus aureus (S. aureus) (NCTC10788), methicillin-resistant
Staphylococcus aureus (MRSA) (NCTC 12493); the Gram-negative bacteria Escherichia coli (E. coli) (NCTC
10418), Pseudomonas aeruginosa (P. aeruginosa) (ATCC 27853) and the yeast Candida albicans (C. albicans)
(NCYC 1467). The microbial suspension which had been inoculated and cultured overnight was diluted
with fresh Mueller-Hinton broth (MHB) to a concentration of 1 × 106 colony-forming units (CFU)/mL.
The sample was initially dissolved in a stock solution of 1024 µM in sodium phosphate-buffered
saline (PBS, pH 7.2) and subsequently double-diluted in MHB to achieve final concentrations of the
peptide from 512 to 1 µM. Peptide solutions were incubated with growth cultures mentioned above
(106 CFU/mL) in 96-well plates for 18 h at 37 ◦C. After that, the absorbance values of the wells
of the 96-well plates were determined at 550 nm using a Synergy HT plate reader (Biolise BioTek,
Winooski, VT, USA) and the MIC was defined as the lowest concentration of peptide that resulted in
no apparent growth of the microorganism. From these wells, 10 µL of the overnight culture was added
to a Mueller-Hinton agar (MHA) plate and cultured at 37 ◦C for 16–20 h. The lowest concentrations
that showed no evidence of colony growth were considered as the MBCs.
4.7. Anti-Biofilm Assays with S. aureus
MBEC assays were based on a modified 2,3,5-triphenyl tetrazolium chloride (TTC) method [42].
Overnight cultures were washed with sterile PBS and diluted with fresh broth to 106 CFU/mL.
For the MBEC assay, 200 µL of inoculum was placed in a flat-bottomed microtiter plate for 48 h to form
mature biofilms. Following sufficient growth time, mature biofilms were washed twice to remove the
planktonic cells and incubated with a series of peptide concentrations (1–512 µM) at 37 ◦C for 20–24 h.
After sufficient growth, plates were washed twice with sterile PBS followed by the addition of fresh
medium (200 µL per well) and stained with 50 µL 1% TTC (g/v) solution for 5 h. After incubation,
200 µL of the supernatant from each well was transferred to a new plate, and their absorbance values
were measured at 470 nm using a Synergy HT plate reader (Biolise BioTek, Winooski, VT, USA).
4.8. Time-Killing Assay with S. aureus
Time-killing curve analyses were carried out by culturing S. aureus in MHB medium in the
presence of three antimicrobial concentrations in doubling dilutions ranging from 4 ×MIC to 1×MIC.
The MIC value referred to the results of antimicrobial assay mentioned above. The sample was initially
dissolved and double-diluted in MHB to achieve final concentrations of the peptide from 8 µM to
2 µM. Bacterial cells which were inoculated and cultured overnight were diluted with peptide-treated
MHB to a concentration of 1 × 106 CFU/mL. Growing bacteria were removed at specified time points
and diluted in sterile PBS in six subsequent 1:10 dilutions (20 µL culture in 180 µL diluent). Twenty µL
droplets of each dilution were spotted on MHA plate and cultured at 37 ◦C. For every concentration
and time point, colonies were counted for the first dilution that resulted in a countable range of 3–100
colonies and the CFU/mL was calculated.
4.9. Haemolytic Assay
–A 96 well plate reader (Biolise BioTek EL808) was used for measuring the optical density of lysis
of cells at 550 nm. A 2% suspension (v/v) was formed with prewashed defibrinated horse erythrocytes
(TCS Biosciences Ltd., Botolph Claydon, Buckingham, UK) and sodium phosphate-buffered saline
(PBS). Peptides were incubated with this 2% suspension in a final concentration range from 1 to 512 µM,
and all the tested samples were kept at a constant 37 ◦C for 2 h. Negative controls employed were PBS
and a 2% red cell suspension in equal volume while positive controls were PBS containing 2% of the
non-ionic detergent, Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) together with a 2% red cell
suspension. The sample supernatants were used to assess the extent of haemolysis by measuring the
optical density (OD) value at 550 nm.
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The haemolysis ratio was calculated using the following equation: % haemolysis = (A − A0)/
(AX − A0) × 100, where ‘A’ is absorbance with peptides of different concentrations, ‘A0’ is absorbance
with negative controls and ‘AX’ is absorbance with positive controls. All OD values were measured at
550 nm.
4.10. Bacterial Cell Membrane Permeability Assay of PSN-PC Using S. aureus
The membrane permeability assay was carried out using SYTOX Green Nucleic Acid Stain
(Life technologies, Carlsbad, CA, USA) [43]. Bacteria were incubated in Tryptic Soy Broth (TSB)
(Sigma-Aldrich, St. Louis, MO, USA) at 37 ◦C overnight, after which 200 µL of bacterial culture was
inoculated into 25 mL TSB and incubated at 37 ◦C for 2.5 h to achieve the logarithmic growth phase.
Next, the supernatant was removed by centrifugation at 1000× g for 10 min at 4 ◦C, and bacterial cells
were washed twice with 5% TSB in 0.85% NaCl solution. The washed bacterial cells were suspended
in 5%TSB to achieve 1 × 108 CFU/mL which was 0.7 at OD 590 nm. Each well of the sample groups in
a black 96 well plate (Fisher Scientific, Leicestershire, UK) contained a volume of 50 µL of bacterial
suspension and 50 µL of peptide solution. Each well of the negative control group was constituted by
a volume of 50 µL of bacterial suspension and 40 µL of 5% TSB. The positive control group was made
by a volume of 50 µL of permeabilised bacterial cell suspension by using 70% isopropanol and 40 µL of
5% TSB. 10 µL of SYTOX green nucleic acid stain was added to each well to form a final concentration
of 5 µM. Meanwhile, the background fluorescence was measured using a volume of 90 µL 5% TSB and
10 µL SYTOX green nucleic acid stain at the same concentration. The black plate was incubated for 2 h
at 37 ◦C in the dark. The fluorescent intensity of each well was recorded using an ELISA plate reader
(Biolise BioTek EL808, Winooski, VT, USA) with excitation at 485 nm and emission at 528 nm.
4.11. Cells Lines and Cell Culture
The human breast cancer cell lines MB435s, MCF-7, the human prostate cancer cell Line
PC3, the non-small cell lung cancer cell line NCl-H157 and the human neuropongioma cell line
U251MG, were separately cultured employing RPMI-1640 culture medium (Invitrogen, Paisley,
UK), or Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, St. Louis, MO, USA), with 1%
penicillin streptomycin solution (Sigma) and 10% fetal bovine serum (FBS) (Sigma) added. The human
microvessel endothelial cell HMEC-1 was employed to evaluate the cytotoxicity of the peptide against
normal human cells. These cells were grown in 10% FBS, 10 ng/mL EGF, 10 mM L-Glutamine, 1%
penicillin streptomycin supplemented MCDB131 medium (Gibco, Paisley, UK). The selected cells were
inoculated into 90 mm culture dishes (Nunc, Roskilde, Denmark) or 75 cm2 culture flasks (Nunc).
Following this, flasks were placed in an incubator with a humidified environment containing 5% CO2.
4.12. Assessment of Cancer Cell Anti-Proliferative Activity Using the MTT Cell Viability Assay
Cancer cell line proliferation and viability were assessed using the MTT cell viability assay [44].
Briefly, each of the cancer cell lines was seeded at a density of 5 × 103 cells per well onto 96 well plates.
Following this, cell lines were prepared with gradient concentrations of peptide and incubated for
24 h. After this, 10 µL of 5 mg/mL yellow coloured MTT solution (Sigma) were added to all wells and
incubated again for 4 h. Once the supernatants were removed by a syringe, 100 µL of DMSO were
added to all wells after gently agitating to completely mix the formazan crystals that had developed.
A Synergy HT plate reader (BioTek, Winooski, VT, USA) was set at 570 nm for recording the absorbance.
4.13. Statistical Analysis
Data were subjected to statistical analysis using Prism (Version 5.0; GraphPad Software Inc.,
San Diego, CA, USA). Error bars in the graphs represent standard error of the mean (SEM) with
experiments performed on more than three sets of replicates.
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Abbreviations
AMPs antimicrobial peptide
CD circular dichroism
DMEM Dulbecco’s modified eagle’s medium
FBS fetal bovine serum
MALDI-TOF MS matrix-assisted laser desorption/ionization time of flight mass spectrometry
MBC minimum bactericidal concentration
MBEC minimal biofilm eradication concentration
MHA Mueller-Hinton agar
MHB Mueller-Hinton broth
MIC minimum inhibitory concentration
MS/MS tandem mass spectrometry
NUP nested universal primer
PBS phosphate-buffered saline
RP-HPLC reverse-phase high performance liquid chromatography
TFA trifluoroacetic acid
TFE trifluoroethanol
TIPS triisopropylsilane
TSB tryptic soy broth
TTC 2,3,5-triphenyl tetrazolium chloride
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